Halozyme Therapeutics | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amarin USD 0 0 2024-09
Amgen USD 56.55B 305M 2024-12
Baxter International USD 10.37B 63M 2024-12
Cytokinetics USD 645.6M 1.1M 2024-12
DBV Technologies USD 0 0 2024-09
Eli Lilly USD 28.53B 518.3M 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Indivior 270M 2M 2024-09
Intra Cellular Therapies USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
MannKind USD 267.29M 191.97M 2024-12
Pfizer USD 57.4B 597M 2024-12
United Therapeutics USD 0 0 2024-12



Halozyme Therapeutics Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.